| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |